BiotechTube
Biosergen

Biosergen

BIOSGN.ST
Stockholm, Sweden· Est.

Biosergen is a biotech company dedicated to developing groundbreaking antifungal drugs. We aim to provide hope and healing to immunocompromised patients, including those with AIDS, cancer, and transplant recipients.

biosergen.net

BIOSGN.ST · Stock Price

SEK 36.40+2.60 (+7.69%)
Market Cap: $9.1M

Historical price data

Market Cap: $9.1MPipeline: 1 drugFounded: 2015HQ: Stockholm, Sweden
Sector Ranking#221 in Small Molecule Drugs

About

Biosergen is a biotech company dedicated to developing groundbreaking antifungal drugs. We aim to provide hope and healing to immunocompromised patients, including those with AIDS, cancer, and transplant recipients.

Small Molecules

Pipeline

1
1 drug in pipeline
DrugIndicationStageWatch
BSG005 or placeboInvasive Fungal InfectionsPhase 1

Competitors

Financiere de Tubize
Financiere de Tubize$9.4B
Orion Corporation
Orion Corporation$9.5B
Recordati
Recordati$10.0B
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals$10.9B
More companies in Small Molecule Drugs →More companies in Sweden →